Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XN4W
|
|||
| Former ID |
DNC013407
|
|||
| Drug Name |
2-(3,4-dimethylphenyl)-1,8-naphthyridine
|
|||
| Synonyms |
CHEMBL235398; 2-(3,4-dimethylphenyl)-1,8-naphthyridine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H14N2
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)C2=NC3=C(C=CC=N3)C=C2)C
|
|||
| InChI |
1S/C16H14N2/c1-11-5-6-14(10-12(11)2)15-8-7-13-4-3-9-17-16(13)18-15/h3-10H,1-2H3
|
|||
| InChIKey |
HNJUUHIKQMSRFO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6525-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.